• Irish Biotech - A Culture of Innovation

    Ireland is world renowned for it's literary greats and picturesque landscapes, but also recently as a rapidly burgeoning hub for innovation in the life sciences. Cycling around Ireland, a group of Irish graduate students set about creating a film to showcase this blossoming field of biotech in the country. Interviewing leaders in Irish government, academia, and venture capital, as well as leaders of Irish biotechs themselves, the film serves to illustrate both the exciting growth of the field as well as the world class infrastructure and support provided by the government to encourage entrepreneurship and commercialization of research in the country. Featured interviewees (in order of appearance): Professor Luke O'Neill - Director of Trinity Biomedical Sciences Institute Professor Jane F...

    published: 16 Sep 2015
  • Niranjan Koirala | Republic of Korea | Asia-Pacific Biotech 2015 | Conferenceseries LLC

    7th Asia-Pacific Biotech Congress The choice of rhamnetin, sakuranetin and genkwanin as nutraceutical, pharmaceutical and cosmeceutical agents Click here for Abstract and Biography: http://biotechnologycongress.com/asia-pacific/speaker/2015/niranjan-koirala-sun-moon-university-republic-of-korea

    published: 12 Apr 2016
  • Premier Biotech Manaufacturing Complex - Sligo Ireland

    CBRE are now offering a unique opportunity to acquire a world class biotech vaccine manufacturing complex in Finisklin Industrial Estate, Sligo, Ireland. The Sligo complex consists of a state-of-the-art biological manufacturing facility, separate quality assurance testing facility and an advanced packaging facility with three storey offices (Fort Gary), specifically designed for veterinary vaccine manufacture.

    published: 15 May 2017
  • European Biotech Week: join the 2017 week-long biotech party across Europe

    At EuropaBio, we realise how important it is to foster dialogue and information sharing in the scientifically complex and often misunderstood area of biotechnology. Our members are committed to developing tools and solutions for some of the world’s main challenges and we have a responsibility to share what we know and to facilitate an open discussion among all stakeholders to accompany these developments. European Biotech Week was first coined in 2013 to mark the 60 year anniversary of the discovery of DNA’s structure. Every year, together with its member National Associations, EuropaBio promotes the week and provides a platform for all biotech supporters to pool their events and raise awareness about the products and the benefits that biotechnology brings in areas as diverse as healthcar...

    published: 03 Apr 2017
  • Republic Day Celebrations 2017 @ Wings Biotech

    India celebrates her 68th Republic Day on 26 January 2017. We at Wings Biotech extended our warm regards to all Indians in the country as well as abroad. It is a proud privilege of Wings Biotech, India's Fastest Growing Healthcare Company to celebrate this historic day with our proud team at our OTC Office. Wings Biotech has been celebrating the Republic Day since it's existence in the 1980s and it gives us sheer pleasure to celebrate this important day of our nation with great joy and festivity! Proud Indians at Wings Biotech Office took part in the most respected Indian National Anthem, and then played a Tricolor Collage Making competition, followed by Musical Evening with performances by our colleagues and friends. Everyone had a blast, followed by evening snacks. Wings Biotech is pro...

    published: 16 Feb 2017
  • Biotech Update Major Breakthrough for Hemispherx BioPharma

    $HEB - SCN's Jane King sits down with CEO Thomas Equels of Hemispherx BioPharma Inc. (NYSE: HEB) and guest analyst Jeffrey Kraws of Crystal Research Associates, to discuss the pharmaceutical company's recent drug approval. From the press release: "Approval for Commercial Sale of Rintatolimod (U.S. Tradename: Ampligen®) to Treat Severe Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in the Argentine Republic" "First Product Approved for ME/CFS Indication Anywhere in the World" "Breakthrough Approval Provides Clear Path for Growth in Latin America and the European Union" Aug. 23, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that it has received approval of its New Drug Application (NDA) from Administr...

    published: 21 Mar 2017
  • Biotech factory for ant-malaria larvae launched in Tanzania

    President Jakaya Kikwete and Prime Minister of the Democratic Republic of Ethiopia Hailemariam Desalegn launching new factory at Kibaha in Coast region to produce biotech products to kill mosquito larvae to eradicating Malaria

    published: 07 Jul 2015
  • Biotechnology song

    A song composed by Joseph Ndunguru and sang by Fountain of Joy Primary School students in Dar es Salaam, Tanzania on March 2013 during the official opening of Biotechnology lab at Mikocheni Agricultural Research Institute (MARI) by His Excellence The President of the United Republic of Tanzania Dr. Jakaya Mrisho Kikwete.

    published: 15 Jul 2013
  • BioPharma Ambition 2016: The convergence of biotech manufacturing and healthcare

    The inaugural BioPharma Ambition Conference was held in Dublin in September 2016. The Irish Pharmaceutical Healthcare Association, BioPharmaChem Ireland and the National Institute for Bioprocessing Research and Training (NIBRT) hosted the multi-platform event at four locations over two days, bringing together international policy leaders, renowned researchers and senior industry personnel. Chaired by PwC’s Johnathon Marshall, this panel discussion features Dr Gerard Fox, senior director and head of Calico collaboration at AbbVie; Dr Bernadette Doyle, vice-president of global technical and NPI, global manufacturing and supply at GlaxoSmithKline; Dr Mike Thien, SVP of global technology and commercialisation at MSD; and Prof Charles Cooney, FT Haslam professor of chemical engineering at Massa...

    published: 09 Jun 2017
  • Active Biotech

    VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities. About The Video: We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy. For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us. Thank you and hope you'll enjoy. IMPORTANT INFORMATION - DISCLAIMER ...

    published: 12 Feb 2017
  • Epitomics Corporate Presentation

    Epitomics, Inc., an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the Company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust na...

    published: 01 Mar 2008
  • Life Sciences

    The Czech Republic has a significant competitive advantages in the Life Sciences sector due to its historically high quality of education in the natural sciences and its track record of breakthrough research and drug development. Today the country is home to a number of global companies in drug production such as Sanofi and Teva, leading suppliers to the Pharma and Biotech industries such as Lonza and Contipro as well as producers of laboratory instrumentation such as Tescan.

    published: 23 Apr 2015
  • Diploma in Biotechnology (DBT) - Singapore Polytechnic

    Diploma in Biotechnology @ SP, JAE code: S72 Diploma in Biotechnology in Singapore Polytechnic offers a broad-based education with diversified modules covering different aspects of life sciences for students to discover and inculcate interest in a particular aspect of life sciences. Find out more @ http://www.sp.edu.sg/wps/portal/vp-spws/schcls.cse.ftdip.biotech Credits go to... Director: Tan Kah Wee Film editors: Tan Kah Wee, Ng Li Jie & Keith Leo Script writer + Video planner: Ng Guo Hao Filming and photographing: - Tan Kah Wee - Keith Leo - Fitria Liyana Bte Ismail Interviewer: - Keith Leo Logistics: - Fitria Liyana Bte Ismail - Chua Sze Min - Ng Chee Sum & Daryl Mah - Dr. Tan Tuan Lin Special Thanks to: Dr. Tan Tuan Lin, Dr Jonathan Loh, Ms. Annabel Ang, Dr. Edmund Lui, Yeo Kai...

    published: 06 Jan 2016
  • BIO-Europe® is where great biotech partnerships begin

    BIO-Europe 2015® | November 2-4 in Munich, Germany | http://www.ebdgroup.com/bioeurope BIO-Europe® is Europe’s largest partnering conference serving the global biotechnology industry. The conference annually attracts international leaders from biotech, pharma and finance along with the most promising startups and emerging companies. It is the “must attend” event for getting business done in the biotech industry. Over 18,000 one-to-one meetings, 4,250 licensing opportunities, 3,200 attendees, 1,850 companies, 160 company presentations, 95 exhibitors, 50 countries, and more… Get involved now!

    published: 30 Jun 2015
  • Indian National Anthem | Wings Biotech 2017

    Wings OTC Team stands up for the most respected National Anthem of India on the eve of 68th Republic Day at our Pitampura Office. We Are Proud to Be Indian. We Are Proud to Make in India. We Are Proud to Clean India. We Are Proud to Teach India. We Are Proud to Startup India. We Are Proud to Spread Health in India. We Are India. Jai Hind. Vande Mataram.

    published: 26 Jan 2017
  • Republic of Two - Let's Escape From Who We Are

    this video was shot in Lyngør, Norway.. music & lyrics : Republic of Two mix & master : Ecson Waldes / Biotech studio director of photography : Vidar Sandtrø, Ole Brodersen / https://www.facebook.com/photobrodersen http://www.olebrodersen.com/ edit : Ole Brodersen, Tomáš Bláha thanks to : Ole Brodersen, Tomáš Bláha,Timon Svoboda, Vidar Sandtrø more info : https://www.facebook.com/republicoftwo http://www.republic-of-two.cz/ Massimo Records 2014 single taken from Silent Disco album

    published: 30 Jan 2014
Irish Biotech - A Culture of Innovation

Irish Biotech - A Culture of Innovation

  • Order:
  • Duration: 1:03:50
  • Updated: 16 Sep 2015
  • views: 5485
videos
Ireland is world renowned for it's literary greats and picturesque landscapes, but also recently as a rapidly burgeoning hub for innovation in the life sciences. Cycling around Ireland, a group of Irish graduate students set about creating a film to showcase this blossoming field of biotech in the country. Interviewing leaders in Irish government, academia, and venture capital, as well as leaders of Irish biotechs themselves, the film serves to illustrate both the exciting growth of the field as well as the world class infrastructure and support provided by the government to encourage entrepreneurship and commercialization of research in the country. Featured interviewees (in order of appearance): Professor Luke O'Neill - Director of Trinity Biomedical Sciences Institute Professor Jane Farrar - CSO at Genable Technologies Professor Mark Ferguson - Director General at SFI, Chief Scientific Advisor to the Irish government Dr Máirín Rafferty - CEO at OncoMark Professor William Gallagher - CSO at OncoMark Senator Professor John Crown - Consultant Medical Oncologist at St. Vincent's University Hospital Dublin Ben Teeling - CEO at Allogen Biotech Pat O'Flynn - CEO at Solvotrin Therapeutics Dr Kieran Guinan - Research Manager at BioAtlantis Dr Sujeeth Neerakkal - Chief Plant Molecular Biologist at BioAtlantis Dr Mark Bruzzi - Director at BioInnovate John Power - CEO at Aerogen Edward McHugh - Managing Director at Algae Health Derek Young - CEO at i360 Medical Dr Barry Heavey - Head of Life Sciences at IDA Ireland Ciarán Meghan - Managing Director at IdentiGEN Dr Peter Milner - Former CEO at Heart Metabolics Dr Alan O'Connell - Partner at Seroba Kernel Dr Keith O'Neill - Former Director of Life Sciences and Food Commercialisation at Enterprise Ireland Kindly supported by Enterprise Ireland. This film forms a part of the LaBiotech World Tour.
https://wn.com/Irish_Biotech_A_Culture_Of_Innovation
Niranjan Koirala  |  Republic of Korea  |  Asia-Pacific Biotech 2015 | Conferenceseries LLC

Niranjan Koirala | Republic of Korea | Asia-Pacific Biotech 2015 | Conferenceseries LLC

  • Order:
  • Duration: 20:57
  • Updated: 12 Apr 2016
  • views: 111
videos
7th Asia-Pacific Biotech Congress The choice of rhamnetin, sakuranetin and genkwanin as nutraceutical, pharmaceutical and cosmeceutical agents Click here for Abstract and Biography: http://biotechnologycongress.com/asia-pacific/speaker/2015/niranjan-koirala-sun-moon-university-republic-of-korea
https://wn.com/Niranjan_Koirala_|_Republic_Of_Korea_|_Asia_Pacific_Biotech_2015_|_Conferenceseries_Llc
Premier Biotech Manaufacturing Complex - Sligo Ireland

Premier Biotech Manaufacturing Complex - Sligo Ireland

  • Order:
  • Duration: 5:48
  • Updated: 15 May 2017
  • views: 27
videos
CBRE are now offering a unique opportunity to acquire a world class biotech vaccine manufacturing complex in Finisklin Industrial Estate, Sligo, Ireland. The Sligo complex consists of a state-of-the-art biological manufacturing facility, separate quality assurance testing facility and an advanced packaging facility with three storey offices (Fort Gary), specifically designed for veterinary vaccine manufacture.
https://wn.com/Premier_Biotech_Manaufacturing_Complex_Sligo_Ireland
European Biotech Week: join the 2017 week-long biotech party across Europe

European Biotech Week: join the 2017 week-long biotech party across Europe

  • Order:
  • Duration: 0:52
  • Updated: 03 Apr 2017
  • views: 0
videos
At EuropaBio, we realise how important it is to foster dialogue and information sharing in the scientifically complex and often misunderstood area of biotechnology. Our members are committed to developing tools and solutions for some of the world’s main challenges and we have a responsibility to share what we know and to facilitate an open discussion among all stakeholders to accompany these developments. European Biotech Week was first coined in 2013 to mark the 60 year anniversary of the discovery of DNA’s structure. Every year, together with its member National Associations, EuropaBio promotes the week and provides a platform for all biotech supporters to pool their events and raise awareness about the products and the benefits that biotechnology brings in areas as diverse as healthcare, agriculture, food, energy and industrial processing. Year upon year, the participation in European Biotech Week has increased with a record 16 countries taking part in the 2016 edition. The 135 initiatives organised in the areas of science, education, policy, media and finance involved thousands of Europeans and ranged from open doors, symposiums, round table discussions and competitions, to hands-on experiments and theatre shows. At a national level, the initiative was even awarded a medal by the Italian President of the Republic in 2015. We strongly encourage all biotech supporters to join forces and participate in whatever way best fits with their mission and resources. The 5th edition will take place between 25 Sept and 1 Oct, 2017. Stay tuned and start planning! www.biotechweek.org
https://wn.com/European_Biotech_Week_Join_The_2017_Week_Long_Biotech_Party_Across_Europe
Republic Day Celebrations 2017 @ Wings Biotech

Republic Day Celebrations 2017 @ Wings Biotech

  • Order:
  • Duration: 3:30
  • Updated: 16 Feb 2017
  • views: 63
videos
India celebrates her 68th Republic Day on 26 January 2017. We at Wings Biotech extended our warm regards to all Indians in the country as well as abroad. It is a proud privilege of Wings Biotech, India's Fastest Growing Healthcare Company to celebrate this historic day with our proud team at our OTC Office. Wings Biotech has been celebrating the Republic Day since it's existence in the 1980s and it gives us sheer pleasure to celebrate this important day of our nation with great joy and festivity! Proud Indians at Wings Biotech Office took part in the most respected Indian National Anthem, and then played a Tricolor Collage Making competition, followed by Musical Evening with performances by our colleagues and friends. Everyone had a blast, followed by evening snacks. Wings Biotech is proud to be Indian and lives to serve the motherland through its efforts and innovation in Healthcare. Jai Hind. -- Join us at www.wingsbiotech.com Follow us on: www.facebook.com/wingsbiotech www.twitter.com/wingsbiotech www.instagram.com/wingsbiotech www.youtube.com/wingsbiotech Know more about our products at: www.facebook.com/diclowin www.facebook.com/orasore
https://wn.com/Republic_Day_Celebrations_2017_Wings_Biotech
Biotech Update Major Breakthrough for Hemispherx BioPharma

Biotech Update Major Breakthrough for Hemispherx BioPharma

  • Order:
  • Duration: 7:03
  • Updated: 21 Mar 2017
  • views: 13
videos
$HEB - SCN's Jane King sits down with CEO Thomas Equels of Hemispherx BioPharma Inc. (NYSE: HEB) and guest analyst Jeffrey Kraws of Crystal Research Associates, to discuss the pharmaceutical company's recent drug approval. From the press release: "Approval for Commercial Sale of Rintatolimod (U.S. Tradename: Ampligen®) to Treat Severe Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in the Argentine Republic" "First Product Approved for ME/CFS Indication Anywhere in the World" "Breakthrough Approval Provides Clear Path for Growth in Latin America and the European Union" Aug. 23, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that it has received approval of its New Drug Application (NDA) from Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica (ANMAT) for commercial sale of rintatolimod (U.S. tradename: Ampligen®) in the Argentine Republic for the treatment of severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The product will be marketed by GP Pharm, Hemispherx's commercial partner in Latin America. We believe that rintatolimod is the first drug to receive approval for this indication anywhere in the world. We also believe that there are no other products in the pipeline for approval, worldwide, for this debilitating disease. A copy of the official approval from ANMAT, translated in English, is available on the Company's website at http://ir.hemispherx.net/Events_Prese.... The approval was based on submission of two pivotal studies, AMP-502 and AMP-516. Safety data also included additional CFS and non-CFS studies for a total of over 800 subjects including over 100 subjects with severe CFS who received Ampligen® for one year or longer. Several post-approval activities are required to be completed before product launch, including manufacturing site inspections and reimbursement evaluation by the Health Services Authority (SSS), the central health authority in Argentina. "Working closely with our partner in this effort, GP Pharm, our team at Hemispherx addressed all medical and scientific issues presented by ANMAT and deserves great credit for this major success. At Hemispherx, we may be small by big pharma standards, but our commitment to addressing this dire unmet medical need makes us mighty," stated Hemispherx CEO Tom Equels . Approval for commercial sale in Argentina provides a platform for potential commercial sales in certain countries within the European Union under regulations that support cross-border pharmaceutical sales of licensed drugs. Hemispherx and GP Pharm are now working to expand the approval of rintatolimod to additional countries with a focus on Latin America. In Europe, approval in a country with a stringent regulatory process in place, such as Argentina, adds further validation for the product as the Early Access Program (EAP) is launched in Europe. "In Argentina, rintatolimod (Ampligen) has just been commercially approved for the severe disabling form of ME/CFS. The number of patients with ME/CFS is estimated to be over three million worldwide, however, only a portion of these have the severe and disabling form of the disease which we are targeting with this drug," stated Tom Equels . "Until now, there has been no commercially available effective treatment and there are no advanced clinical candidates, other than rintatolimod, that we are aware of. This commercial approval in Argentina will dramatically improve our ability to treat patients suffering from severe ME/CFS in Latin America. We continue to work aggressively to clarify a path toward approval for those with severe ME/CFS in the United States, where we have Orphan Drug status, and therefore seven years of product exclusivity upon approval. We are greatly encouraged by this new regulatory approval in Argentina. This is the most significant accomplishment to date in Hemispherx's plan to bring our drug to severe sufferers of ME/CFS worldwide." "We have worked diligently with Hemispherx to get to this point, and are now preparing for the commercial launch of rintatolimod for ME/CFS in Argentina," commented Jorge Braver , chief executive officer of GP Pharm Latin America. "Looking ahead, we will continue to seek approval in additional Latin American countries." Crystal Research Associates provides investor-based research and corporate communications services to increase the visibility of innovative and growing private and public companies that represent extraordinary investment opportunities. Regardless of the size of the client, our independent research and advisory services provide additional value and assistance in realizing a company’s goals, enabling it to achieve its fullest potential. www.crystalra.com
https://wn.com/Biotech_Update_Major_Breakthrough_For_Hemispherx_Biopharma
Biotech factory for ant-malaria larvae  launched in Tanzania

Biotech factory for ant-malaria larvae launched in Tanzania

  • Order:
  • Duration: 26:28
  • Updated: 07 Jul 2015
  • views: 658
videos
President Jakaya Kikwete and Prime Minister of the Democratic Republic of Ethiopia Hailemariam Desalegn launching new factory at Kibaha in Coast region to produce biotech products to kill mosquito larvae to eradicating Malaria
https://wn.com/Biotech_Factory_For_Ant_Malaria_Larvae_Launched_In_Tanzania
Biotechnology song

Biotechnology song

  • Order:
  • Duration: 4:01
  • Updated: 15 Jul 2013
  • views: 918
videos
A song composed by Joseph Ndunguru and sang by Fountain of Joy Primary School students in Dar es Salaam, Tanzania on March 2013 during the official opening of Biotechnology lab at Mikocheni Agricultural Research Institute (MARI) by His Excellence The President of the United Republic of Tanzania Dr. Jakaya Mrisho Kikwete.
https://wn.com/Biotechnology_Song
BioPharma Ambition 2016: The convergence of biotech manufacturing and healthcare

BioPharma Ambition 2016: The convergence of biotech manufacturing and healthcare

  • Order:
  • Duration: 11:51
  • Updated: 09 Jun 2017
  • views: 29
videos
The inaugural BioPharma Ambition Conference was held in Dublin in September 2016. The Irish Pharmaceutical Healthcare Association, BioPharmaChem Ireland and the National Institute for Bioprocessing Research and Training (NIBRT) hosted the multi-platform event at four locations over two days, bringing together international policy leaders, renowned researchers and senior industry personnel. Chaired by PwC’s Johnathon Marshall, this panel discussion features Dr Gerard Fox, senior director and head of Calico collaboration at AbbVie; Dr Bernadette Doyle, vice-president of global technical and NPI, global manufacturing and supply at GlaxoSmithKline; Dr Mike Thien, SVP of global technology and commercialisation at MSD; and Prof Charles Cooney, FT Haslam professor of chemical engineering at Massachusetts Institute of Technology. For more, see https://www.siliconrepublic.com Follow us on Twitter: https://twitter.com/siliconrepublic Like us on Facebook: https://www.facebook.com/siliconrepublic
https://wn.com/Biopharma_Ambition_2016_The_Convergence_Of_Biotech_Manufacturing_And_Healthcare
Active Biotech

Active Biotech

  • Order:
  • Duration: 2:01
  • Updated: 12 Feb 2017
  • views: 28
videos
VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities. About The Video: We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy. For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us. Thank you and hope you'll enjoy. IMPORTANT INFORMATION - DISCLAIMER THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances. Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein. DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements. EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness. FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com . Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein. Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates. You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade. COPYRIGHTFAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner . Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article. If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email: company@whyinvestin.com
https://wn.com/Active_Biotech
Epitomics Corporate Presentation

Epitomics Corporate Presentation

  • Order:
  • Duration: 10:14
  • Updated: 01 Mar 2008
  • views: 9736
videos
Epitomics, Inc., an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the Company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The Company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The Company is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China.
https://wn.com/Epitomics_Corporate_Presentation
Life Sciences

Life Sciences

  • Order:
  • Duration: 1:02
  • Updated: 23 Apr 2015
  • views: 22
videos
The Czech Republic has a significant competitive advantages in the Life Sciences sector due to its historically high quality of education in the natural sciences and its track record of breakthrough research and drug development. Today the country is home to a number of global companies in drug production such as Sanofi and Teva, leading suppliers to the Pharma and Biotech industries such as Lonza and Contipro as well as producers of laboratory instrumentation such as Tescan.
https://wn.com/Life_Sciences
Diploma in Biotechnology (DBT) - Singapore Polytechnic

Diploma in Biotechnology (DBT) - Singapore Polytechnic

  • Order:
  • Duration: 5:00
  • Updated: 06 Jan 2016
  • views: 376
videos
Diploma in Biotechnology @ SP, JAE code: S72 Diploma in Biotechnology in Singapore Polytechnic offers a broad-based education with diversified modules covering different aspects of life sciences for students to discover and inculcate interest in a particular aspect of life sciences. Find out more @ http://www.sp.edu.sg/wps/portal/vp-spws/schcls.cse.ftdip.biotech Credits go to... Director: Tan Kah Wee Film editors: Tan Kah Wee, Ng Li Jie & Keith Leo Script writer + Video planner: Ng Guo Hao Filming and photographing: - Tan Kah Wee - Keith Leo - Fitria Liyana Bte Ismail Interviewer: - Keith Leo Logistics: - Fitria Liyana Bte Ismail - Chua Sze Min - Ng Chee Sum & Daryl Mah - Dr. Tan Tuan Lin Special Thanks to: Dr. Tan Tuan Lin, Dr Jonathan Loh, Ms. Annabel Ang, Dr. Edmund Lui, Yeo Kai Wen, Samuel Lim, Loo Jun Bin, Chng Pheng Siong, Claire Lee, Tay Yu Pei, Kong Kay Yan Petrina, Kavan Chua, Brian Lim, Ray Lim Background music: Credits to E-Soundtrax YouTube channel.
https://wn.com/Diploma_In_Biotechnology_(Dbt)_Singapore_Polytechnic
BIO-Europe® is where great biotech partnerships begin

BIO-Europe® is where great biotech partnerships begin

  • Order:
  • Duration: 1:04
  • Updated: 30 Jun 2015
  • views: 2317
videos
BIO-Europe 2015® | November 2-4 in Munich, Germany | http://www.ebdgroup.com/bioeurope BIO-Europe® is Europe’s largest partnering conference serving the global biotechnology industry. The conference annually attracts international leaders from biotech, pharma and finance along with the most promising startups and emerging companies. It is the “must attend” event for getting business done in the biotech industry. Over 18,000 one-to-one meetings, 4,250 licensing opportunities, 3,200 attendees, 1,850 companies, 160 company presentations, 95 exhibitors, 50 countries, and more… Get involved now!
https://wn.com/Bio_Europe®_Is_Where_Great_Biotech_Partnerships_Begin
Indian National Anthem | Wings Biotech 2017

Indian National Anthem | Wings Biotech 2017

  • Order:
  • Duration: 2:01
  • Updated: 26 Jan 2017
  • views: 125
videos
Wings OTC Team stands up for the most respected National Anthem of India on the eve of 68th Republic Day at our Pitampura Office. We Are Proud to Be Indian. We Are Proud to Make in India. We Are Proud to Clean India. We Are Proud to Teach India. We Are Proud to Startup India. We Are Proud to Spread Health in India. We Are India. Jai Hind. Vande Mataram.
https://wn.com/Indian_National_Anthem_|_Wings_Biotech_2017
Republic of Two - Let's Escape From Who We Are

Republic of Two - Let's Escape From Who We Are

  • Order:
  • Duration: 3:51
  • Updated: 30 Jan 2014
  • views: 8936
videos
this video was shot in Lyngør, Norway.. music & lyrics : Republic of Two mix & master : Ecson Waldes / Biotech studio director of photography : Vidar Sandtrø, Ole Brodersen / https://www.facebook.com/photobrodersen http://www.olebrodersen.com/ edit : Ole Brodersen, Tomáš Bláha thanks to : Ole Brodersen, Tomáš Bláha,Timon Svoboda, Vidar Sandtrø more info : https://www.facebook.com/republicoftwo http://www.republic-of-two.cz/ Massimo Records 2014 single taken from Silent Disco album
https://wn.com/Republic_Of_Two_Let's_Escape_From_Who_We_Are